Skip to content

Effects of Allium Hookeri on Blood Glucose

An 8 Week, Randomized, Double-blind, Placebo-controlled Crossover Clinical Trial of Allium Hookeri Root Extract on Anti-diabetic Effects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03330366
Enrollment
30
Registered
2017-11-06
Start date
2015-11-24
Completion date
2018-03-31
Last updated
2018-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PreDiabetes

Brief summary

The researchers investigated the anti-diabetic effects of Allium hookeri root extract for Korean prediabetic participants.

Detailed description

Allium hookeri root is widely consumed as a vegetable and herbal medicine in Asia. Although the antidiabetic activities of Allium hookeri have been documented in animal studies, the improved effects of Allium hookeri on human are not clear. Therefore, in this study, the researchers investigated whether Allium hookeri root extract could be effective in reducing the risk of type 2 diabetes in individuals with prediabetes.

Interventions

DIETARY_SUPPLEMENTAllium hookeri extract

take two capsules per day (486 mg/day) for 8 weeks

DIETARY_SUPPLEMENTPlacebo

take two capsules per day

Sponsors

Chonbuk National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Fasting glucose 100\ 126 mg/dl

Exclusion criteria

* Significant variation in weight (more 10%) in the past 3 months * Treatment by hypoglycemic and hypolipidemic drug therapy within the past three months * Type 1 diabetes or HbA1c\>9.0% * Cardiovascular disease * Hypoglycemic agent, obesity medicine, and lipid lowering agent within past 6 months or blood sugar, obesity, and lipid improvement functional foods within past 2 monts * Pregnancy or breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Changes of blood glucose during OGTT8 weeksChanges of fasting and postprandial glucose during OGTT were assessed before and after the intervention

Secondary

MeasureTime frameDescription
Changes of HbA1c8 weekChanges of HbA1c were assessed before and after the intervention
Changes of blood insulin8 weekChanges of blood insulin were assessed before and after the intervention
Changes of C-peptide8 weekChanges of C-peptide were assessed before and after the intervention

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026